Cardiac Cath Suite

I/Dx SuiteCT Suite

Committed to Science, Committed to You.™

THE CASE FOR TAGGING

Bracco’s TagitolTM V (barium sulfate suspension 40% w/v, 30% w/w) was the fecal tagging Clinical Standard used in the ACRIN CT Colonography Trial.1 Fecal tagging before CTC enhances the assessment of fecal residue in the colon and has proven effi cient in lesion detection.2

Indications and Usage:Tagitol V is a low-volume radiopaque marker that blends into stool as it forms. With just a 20mL dose with breakfast, lunch and dinner the day prior to the exam, Tagitol V provides immediate, visible identifi cation of retained feces via comparative density analysis, simplifying the distinction between tagged feces and colonic abnormality.

IMPORTANT SAFETY INFORMATION:For use in opacifying residual stool in the colon during CTC. This product should not be used in patients with known or suspected gastric and intestinal perforation, or hypersensitivity to barium sulfate or any component of this barium sulfate formulation. Rarely, severe and occasionally fatal allergic reactions have been reported following administration of barium sulfate contrast agents.

Please see Full Prescribing Information included in the pocket.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

THE ONLY FECAL TAGGING AGENT FOR CT COLONOGRAPHY.

Cardiac Cath Suite

I/Dx SuiteCT Suite

Committed to Science, Committed to You.™

Tagitol V, the only fecal tagging agent for CT Colonography

Recognizing the role of patient compliance for effective fecal tagging, Bracco developed low volume, pleasant-tasting Tagitol V.

Distinguishing pathology from residual stool is one of the most challenging aspects of any CT exam of the colon. Even with a trained eye, experienced radiologists may have diffi culty identifying stool versus pathology.

Fecal tagging before CT colonography enhances the assessment of fecal residue in the colon and has proven effi cient in lesion detection.2

THE RIGHT CHOICE FOR CTC

Simplicity for the Patient• Small bottles for portability• Pleasant apple fl avor• Easy to drink• Low volume

Convenience for the Practitioner• 3 small, prepackaged unit doses• Easy storage• Simple delivery to the patient

Image courtesy of Dr. Judy Yee, UCSF

© 2015 Bracco Diagnostics Inc. All Rights Reserved.15-0622-JW

Indications and Usage:Tagitol V is a low-volume radiopaque marker that blends into stool as it forms. With just a 20mL dose with breakfast, lunch and dinner the day prior to the exam, Tagitol V provides immediate, visible identifi cation of retained feces via comparative density analysis, simplifying the distinction between tagged feces and colonic abnormality.

IMPORTANT SAFETY INFORMATION:For use in opacifying residual stool in the colon during CTC. This product should not be used in patients with known or suspected gastric and intestinal perforation, or hypersensitivity to barium sulfate or any component of this barium sulfate formulation. Rarely, severe and occasionally fatal allergic reactions have been reported following administration of barium sulfate contrast agents.

Please see Full Prescribing Information included in the pocket. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

References: 1. Johnson CD, et al. N Engl J Med 2008;359:1207-17 2. Lefere P, et al. AJR 2005; 184:1836-1842.

Tagitol V is a trademark of E-Z-EM, Inc.

Manufactured by E-Z-EM Canada Inc., for E-Z-EM, Inc., a subsidiary of Bracco Diagnostics Inc., Monroe Twp., NJ 08831.

Email: Bracco@diag.bracco.comWebsite: http://imaging.bracco.com/us-en/products-and-solutions/contrast-media/tagitol-v

Customer Service:1-877-BRACCO 9 (1-877-272-2269)

Professional Services:1-800-257-5181 (option 1)

ORDERING INFORMATION

Description Product Code390802Tagitol V Barium Sulfate Radiopaque Marker for Virtual Colonoscopy

(each patient pack includes 3x20 ml bottles; 24 patient packs per shipping case)